NCT01795950View on ClinicalTrials.gov

Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)

PHASE1TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

January 31, 2016

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

PLX-PAD

intravenous administration of a single dose of PLX-PAD cells

Trial Locations (2)

4032

The Prince Charles Hospital, Brisbane

Unknown

The Alfred Hospital, Melbourne

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY